Prostate cancer research advances | Dana-Farber Cancer Institute

Prostate cancer on the rise | Dana-Farber Cancer InstituteПодробнее

The Evolution of Systemic Therapy for Newly Diagnosed Multiple Myeloma, Dana-Farber Cancer InstituteПодробнее

Myeloma 101: Diagnosis, Prognosis & Risk | Dana-Farber Cancer InstituteПодробнее

2022 San Antonio Breast Cancer Symposium Update on MBC | 2022-2023 EMBRACE MBC Virtual Forum SeriesПодробнее

Esophageal cancer research advances | Dana-Farber Cancer InstituteПодробнее

Prostate Cancer Conference Highlights from ASCO 2022Подробнее

MIA: Haitham Elmarakeby, Biologically informed ML for cancer discovery; Primer by Felix DietleinПодробнее

Rare Genitourinary Cancer: Research AdvancesПодробнее

Genetic Counseling/Prostate Cancer research presented by Dana-Farber at ASCO 20Подробнее

New Research in Metastatic Breast Cancer | SABCS 2019Подробнее

ER-Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019Подробнее

Metastatic Breast Cancer Forum 2018: Triple Negative Breast Cancer | Dana-Farber Cancer InstituteПодробнее

Dr. Eric Jacobsen on Rosia-Dorfman disease | Dana-Farber Cancer InstituteПодробнее

Cancer Research Talks: Dr Christopher Sweeney - Prostate CancerПодробнее

Multiple Myeloma Symposium: Diagnosis and Risk Assessment | Dana-Farber Cancer InstituteПодробнее

Clinical Trials for Brain Tumor Patients | Dana-Farber Cancer InstituteПодробнее

Profile: large-scale genomic database project | Dana-Farber Cancer InstituteПодробнее